For many people with rheumatoid arthritis, the much cheaper traditional, disease-modifying anti-rheumatic drugs (DMARDs) appear to work just as well as newer TNF blockers that target the underlying disease process, a large study shows.
Study: No Benefit to Costly Arthritis DrugsCourtesy WebMD Health Wed, 10/21/2009 - 16:44
For many people with rheumatoid arthritis, the much cheaper traditional, disease-modifying anti-rheumatic drugs (DMARDs) appear to work just as well as newer TNF blockers that target the underlying disease process, a large study shows. More related itemsRheumatoid Arthritis: New Treatment Target
ACR: No Increase in Infections with Anti-TNF Therapy...
ACR: Joint Surgery Declines Hint at Better RA Drugs...
|
Popular by tags WeekMonth |
Post new comment